Data from New Analyses of Studies with Veltassa® Presented at 53rd European Renal Association Congress
22 mai 2016 11h00 HE
|
Relypsa, Inc.
REDWOOD CITY, Calif., May 22, 2016 (GLOBE NEWSWIRE) -- Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical company, today announced that data from new analyses of studies with Veltassa® (patiromer) for...